Pharmacokinetic evaluation of visnagin and ammi visnaga aqueous extract after oral administration in rats

Planta Medica

Volumn 78, Issue 17, 2012, Pages 1831-1836

  Haug, Karing ^a   Weber, Benjamin ^a   Hochhaus, Guenther ^a   Butterweck, Veronika ^a,b  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF APPLIED SCIENCES AND ARTS NORTHWESTERN SWITZERLAND   (Switzerland)

Author keywords

Ammi visnaga; Apiaceae; kidney stones; nonlinear pharmacokinetics; synergy; visnagin

Indexed keywords

AMMI VISNAGA EXTRACT; BETA CYCLODEXTRIN SULFOBUTYL ETHER; VISNAGIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG MEGADOSE; LIQUID CHROMATOGRAPHY; LOW DRUG DOSE; MALE; MASS SPECTROMETRY; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; RAT; SOLVENT EXTRACTION; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; AMMI; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; KHELLIN; KIDNEY CALCULI; MALE; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY;

AMMI VISNAGA; APIACEAE; RATTUS;

EID: 84870406914     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0032-1315393     Document Type: Article

References (20)

1. Gunaydin K., Beyazit N. The chemical investigations on the ripe fruits of Ammi visnaga (Lam.) Lamarck growing in Turkey. Nat Prod Res: 2004; 18 169 175
2. Scales C. D. Jr., Smith A. C., Hanley J. M., Saigal C. S. Prevalence of kidney stones in the United States. Eur Urol: 2012; 62 160 165
3. Stamatelou K. K., Francis M. E., Jones C. A., Nyberg L. M., Curhan G. C. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int: 2003; 63 1817 1823
4. Romero V., Akpinar H., Assimos D. G. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol: 2010; 12 e86 e96
5. Chandhoke P. S. Evaluation of the recurrent stone former. Urol Clin North Am: 2007; 34 315 322
6. Worcester E. M., Coe F. L. Nephrolithiasis. Prim Care: 2008; 35 369 391 vii
7. Butterweck V., Khan S. R. Herbal medicines in the management of urolithiasis: alternative or complementary? Planta Med: 2009; 75 1095 1103
8. Khan Z. A., Assiri A. M., Al-Afghani H. M., Maghrabi T. M. Inhibition of oxalate nephrolithiasis with Ammi visnaga (AI-Khillah). Int Urol Nephrol: 2001; 33 605 608
9. Vanachayangkul P., Byer K., Khan S., Butterweck V. An aqueous extract of Ammi visnaga fruits and its constituents khellin and visnagin prevent cell damage caused by oxalate in renal epithelial cells. Phytomedicine: 2010; 17 653 658
10. Vanachayangkul P., Chow N., Khan S. R., Butterweck V. Prevention of renal crystal deposition by an extract of Ammi visnaga L. and its constituents khellin and visnagin in hyperoxaluric rats. Urol Res: 2011; 39 189 195
11. Haug K. G., Weber B., Hochhaus G., Butterweck V. Nonlinear pharmacokinetics of visnagin in rats after intravenous bolus administration. Eur J Pharm Sci: 2012; 45 79 89
12. Nahrstedt A., Butterweck V. Lessons learned from herbal medicinal products: the example of St. Johns Wort. J Nat Prod: 2010; 73 1015 1021
13. List P. H., Schmid W., Weil E. Pure substance or galenic preparation? Attempt at a clarification on sample of Belladonna extract. Arzneimittelforschung: 1969; 19 181 185
14. Butterweck V., Petereit F., Winterhoff H., Nahrstedt A. Solubilized hypericin and pseudohypericin from Hypericum perforatum exert antidepressant activity in the forced swimming test. Planta Med: 1998; 64 291 294
15. Zeller W., Weber H., Panoussis B., Burge T., Bergmann R. Refinement of blood sampling from the sublingual vein of rats. Lab Anim: 1998; 32 369 376
16. Hollander M., Wolfe D. A. Nonparametric statistical methods. 2nd edition. New York Wiley & Sons: 1999; 106 125
17. Gibaldi M., Perrier D. Pharmacokinetics. 2nd edition. New York Marcel Dekker, Inc.: 1982; 319 353
18. Rajewski R. A., Stella V. J. Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J Pharm Sci: 1996; 85 1142 1169
19. Stella V. J., Rajewski R. A. Cyclodextrins: their future in drug formulation and delivery. Pharm Res: 1997; 14 556 567
20. Stella V. J., Rao V. M., Zannou E. A., Zia V. V. Mechanisms of drug release from cyclodextrin complexes. Adv Drug Deliv Rev: 1999; 36 3 16